• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
COVID-19 associated pulmonary aspergillosis (CAPA): An added potential burden on India's pre-existing fungal superinfection.2019冠状病毒病相关肺曲霉病(CAPA):给印度原有的真菌重叠感染增添了潜在负担。
Clin Epidemiol Glob Health. 2022 Jan-Feb;13:100960. doi: 10.1016/j.cegh.2021.100960. Epub 2022 Jan 4.
2
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.COVID-19 机械通气患者真菌感染:法国多中心 MYCOVID 研究。
Lancet Respir Med. 2022 Feb;10(2):180-190. doi: 10.1016/S2213-2600(21)00442-2. Epub 2021 Nov 26.
3
Protective Effect of Indole-3-Aldehyde in Murine COVID-19-Associated Pulmonary Aspergillosis.吲哚 - 3 - 醛对小鼠新冠病毒相关肺曲霉病的保护作用
J Fungi (Basel). 2024 Jul 22;10(7):510. doi: 10.3390/jof10070510.
4
COVID-19 and mucormycosis superinfection: the perfect storm.COVID-19 与毛霉菌感染:完美风暴。
Infection. 2021 Oct;49(5):833-853. doi: 10.1007/s15010-021-01670-1. Epub 2021 Jul 24.
5
COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit Patients from Poland.波兰重症监护病房患者中的新型冠状病毒肺炎相关肺曲霉病
J Fungi (Basel). 2023 Jun 13;9(6):666. doi: 10.3390/jof9060666.
6
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.新型冠状病毒肺炎相关肺曲霉病诊断与临床管理特别工作组报告
Intensive Care Med. 2021 Aug;47(8):819-834. doi: 10.1007/s00134-021-06449-4. Epub 2021 Jun 23.
7
COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan.重症新型冠状病毒肺炎(COVID-19)患者中与COVID-19相关的肺曲霉病(CAPA):一项来自巴基斯坦的观察性研究。
Mycoses. 2020 Aug;63(8):766-770. doi: 10.1111/myc.13135. Epub 2020 Jul 18.
8
COVID-19-Associated Pulmonary Aspergillosis (CAPA).新型冠状病毒肺炎相关肺曲霉病(CAPA)
J Intensive Med. 2021 Aug 7;1(2):71-80. doi: 10.1016/j.jointm.2021.07.001. eCollection 2021 Oct.
9
Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave.第一波疫情期间新型冠状病毒肺炎相关肺曲霉病(CAPA)的区域影响
J Fungi (Basel). 2022 Jan 19;8(2):96. doi: 10.3390/jof8020096.
10
A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic.在疫情第三波期间对危重症患者进行 COVID-19 相关肺曲霉病的筛查研究。
Mycoses. 2022 Jul;65(7):724-732. doi: 10.1111/myc.13466. Epub 2022 May 25.

引用本文的文献

1
Loss of pulmonary tissue protection and neutrophil microbicidal defects promote severe infection during influenza A virus infection.肺部组织保护功能丧失和中性粒细胞杀菌缺陷会加剧甲型流感病毒感染期间的严重感染。
Infect Immun. 2025 Sep 9;93(9):e0023425. doi: 10.1128/iai.00234-25. Epub 2025 Aug 11.
2
Quality of life after prosthodontic rehabilitation in patients with bilateral total maxillectomy due to COVID-19-associated mucormycosis of the maxilla.因 COVID-19 相关上颌骨毛霉菌病行双侧全上颌骨切除术患者的口腔修复重建后的生活质量
Arch Craniofac Surg. 2024 Dec;25(6):285-291. doi: 10.7181/acfs.2024.00486. Epub 2024 Dec 20.
3
Evaluation of Antifungal Properties of Titania P25.二氧化钛P25的抗真菌特性评估
Micromachines (Basel). 2022 Oct 28;13(11):1851. doi: 10.3390/mi13111851.
4
Does COVID-19 lockdowns have impacted on global dengue burden? A special focus to India.新冠疫情封锁措施对全球登革热负担有影响吗?特别关注印度。
BMC Public Health. 2022 Jul 22;22(1):1402. doi: 10.1186/s12889-022-13720-w.

本文引用的文献

1
Emergence of a medley of invasive fungal infections amidst the coronavirus disease 2019 (COVID-19) pandemic in India.在印度2019冠状病毒病(COVID-19)大流行期间,多种侵袭性真菌感染出现。
Antimicrob Steward Healthc Epidemiol. 2021 Nov 2;1(1):e40. doi: 10.1017/ash.2021.198. eCollection 2021.
2
Tuberculosis amidst COVID-19 pandemic in India: unspoken challenges and the way forward.印度新冠疫情期间的结核病:潜在挑战与未来之路
Trop Med Health. 2021 Oct 21;49(1):84. doi: 10.1186/s41182-021-00377-1.
3
Dual burden of Zika and COVID-19 in India: challenges, opportunities and recommendations.印度寨卡病毒病和2019冠状病毒病的双重负担:挑战、机遇与建议
Trop Med Health. 2021 Oct 18;49(1):83. doi: 10.1186/s41182-021-00378-0.
4
Antifungal drug shortage in India amid an increase in invasive fungal functions during the coronavirus disease 2019 (COVID-19) pandemic.在2019年冠状病毒病(COVID-19)大流行期间,印度出现侵袭性真菌感染增加的同时,抗真菌药物短缺。
Infect Control Hosp Epidemiol. 2022 Dec;43(12):1965-1966. doi: 10.1017/ice.2021.426. Epub 2021 Sep 23.
5
COVID-19 vaccination strategies and policies in India: The need for further re-evaluation is a pressing priority.印度的新冠疫苗接种策略与政策:进一步重新评估的必要性是当务之急。
Int J Health Plann Manage. 2022 May;37(3):1847-1850. doi: 10.1002/hpm.3321. Epub 2021 Sep 12.
6
The risk of cutaneous mucormycosis associated with COVID-19: A perspective from Pakistan.COVID-19 相关皮肤毛霉菌病的风险:来自巴基斯坦的观点。
Int J Health Plann Manage. 2022 Mar;37(2):1157-1159. doi: 10.1002/hpm.3311. Epub 2021 Sep 2.
7
Rampant Increase in Cases of Mucormycosis in India and Pakistan: A Serious Cause for Concern during the Ongoing COVID-19 Pandemic.印度和巴基斯坦的毛霉菌病病例急剧增加:在当前 COVID-19 大流行期间令人严重关切的问题。
Am J Trop Med Hyg. 2021 Aug 30;105(5):1144-1147. doi: 10.4269/ajtmh.21-0608.
8
Mucormycosis, conflicts and COVID-19: A deadly recipe for the fragile health system of Afghanistan.毛霉菌病、冲突与新冠疫情:给阿富汗脆弱卫生系统带来的致命组合。
Int J Health Plann Manage. 2022 Jan;37(1):543-546. doi: 10.1002/hpm.3292. Epub 2021 Jul 31.
9
Drug resistant White fungus: another catastrophic fungus emergence amidst COVID-19 in India.耐药白真菌:印度新冠疫情期间出现的又一种灾难性真菌。
Pathog Glob Health. 2021 Oct-Dec;115(7-8):435-436. doi: 10.1080/20477724.2021.1960762. Epub 2021 Jul 27.
10
COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.COVID-19 和毛霉菌病综合征:印度崩溃的医疗体系面临的双重健康威胁。
Trop Med Int Health. 2021 Sep;26(9):1016-1018. doi: 10.1111/tmi.13641. Epub 2021 Jun 24.

2019冠状病毒病相关肺曲霉病(CAPA):给印度原有的真菌重叠感染增添了潜在负担。

COVID-19 associated pulmonary aspergillosis (CAPA): An added potential burden on India's pre-existing fungal superinfection.

作者信息

Lal Priyanka Mohan, Arif Aabiya, Mohan Anmol, Rackimuthu Sudhan, Hasan Mohammad Mehedi, Islam Zarmina, Uday Utkarsha, Wara Um-Ul-, Shaikh Muhammad Taha Arshad, Essar Mohammad Yasir

机构信息

Ziauddin Medical University, Karachi, Pakistan.

Karachi Medical & Dental College, Karachi, Pakistan.

出版信息

Clin Epidemiol Glob Health. 2022 Jan-Feb;13:100960. doi: 10.1016/j.cegh.2021.100960. Epub 2022 Jan 4.

DOI:10.1016/j.cegh.2021.100960
PMID:35005301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8723756/
Abstract

The ongoing pandemic that initiated in Wuhan, China, has been an international public health emergency since January 2020. India has been battling a brutal COVID-19's second wave since April 2021. The healthcare system was struggling with a substantial increase in COVID-19 cases when the lack of necessary resources further aroused a major setback. Opportunistic fungal infections, specifically mucormycosis and candidiasis have become a pressing matter of concern. Recent cases of aspergillosis have also heightened public alarm. Hence, call for an immediate response to this public health crisis is the need of the hour by establishing countrywide surveillance, diagnostic, and management system, as well as public awareness to alleviate the burden of COVID-19 and fungal infections in India.

摘要

自2020年1月起,始于中国武汉的这场持续的疫情已成为国际公共卫生紧急事件。自2021年4月以来,印度一直在抗击残酷的新冠疫情第二波高峰。当医疗系统因新冠病例大幅增加而不堪重负时,必要资源的匮乏更是雪上加霜。机会性真菌感染,尤其是毛霉菌病和念珠菌病,已成为令人紧迫担忧的问题。近期的曲霉病病例也加剧了公众的恐慌。因此,当务之急是通过建立全国范围的监测、诊断和管理系统以及提高公众意识,来立即应对这一公共卫生危机,以减轻印度新冠疫情和真菌感染的负担。